Retinal Detachment Clinical Trial
Official title:
Prophylactic Laser Photocoagulation and Vitrectomy for Acute Retinal Necrosis
Acute retinal necrosis (ARN) is a rare infectious retinitis which can potentially lead to
devastating visual outcomes. ARN is diagnosed on the basis of the clinical appearance and
disease course according to the diagnostic criteria proposed by the American Uveitis Society:
(1) one or more foci of retinal necrosis with discrete borders in the peripheral retina; (2)
rapid progression in the absence of antiviral therapy; (3) circumferential spread; (4)
occlusive vasculopathy with arteriolar involvement; and (5) a prominent inflammatory reaction
in the vitreous and anterior chambers.
Herpesvirus infection, especially varicella-zoster virus (VZV) and herpes simplex virus
(HSV), was presumed to be the pathogenic agent in the pathogenesis of ARN. Medical treatment
with systemic antiviral agent had been the base of the therapy of ARN for decades and such
treatment usually result in regression of retinitis.
However, the visual outcome of ARN remains poor. The major causes of poor visual prognosis in
ARN are retinal detachment and optic nerve or macular involvement by ischemic vasculopathy.
Less frequent causes include macular hole formation, macular pucker, or hypotony.
Rhegmatogenous retinal detachment may occur in 75 % of the untreated eyes. It may occur weeks
to months after the onset of inflammation due to delayed formation of retinal breaks, which
result from the combination of necrotic retina and vitreoretinal traction.
Therefore, application of argon laser retinopexy prophylactically posterior to necrotic
retina or prophylactic vitrectomy to reduce inflammatory factors and the vitreoretinal
traction had been used to protect the healthy area from detachment. However, the results were
varied and there is no consensus on the efficacy and indications of those prophylactic
procedures. We had applied the prophylactic procedure in our treatment for ARN. We aim to
access the efficacy of the treatment strategy of ARN and the correlated factors to the
outcomes.
Between 1995 and 2013, the charts of 20 patients (21 eyes) with a clinical diagnosis of ARN
and a complete ophthalmic examination at National Taiwan University Hospital were reviewed.
The study was approved by the Ethics Committee and Institutional Review Board of National
Taiwan University Hospital.
The clinical data recorded included patient demographics, refractive error, lens status, best
corrected visual acuity (BCVA), all treatments and retinal anatomical status. Visual acuities
and examination findings were recorded at presentation and subsequent follow-up periods for
at least 6 months. The area of retina involved was determined by review of retinal drawings
and fundus photos by single reader.
All the patients were admitted for intravenous injection of Acyclovir (30mg/kg/day, in 3
divided doses) for 10-14 days and then shifted to oral Acyclovir (30mg/kg/day) at least for
further 10-14 days. Systemic corticosteroid and Aspirin were also given. Prophylactic laser
photocoagulation was arranged on normal retina to surround the posterior edge of the active
lesions if the media was clear enough to approach. If vitritis persisted without improvement
under systemic antiviral agent or retinal detachment was noted, vitrectomy would be
performed. Visual acuities and retinal anatomical results were recorded during follow-up
after procedures. The visual acuity was converted to logarithm of the minimum angle of
resolution (logMAR) values for statistical analysis.
Statistical analysis The continuous values are expressed as means ± standard deviation (SD).
The differences among the continuous variables were assessed using the Mann-Whitney U test.
Non-continuous variables were analyzed by Fisher's exact test. The level of statistical
significance was set at p < 0.05.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03332758 -
Inflammasomes in Cell Death in FTMH, ERM, and RRD
|
||
Completed |
NCT03660384 -
Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT04535622 -
Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery
|
N/A | |
Recruiting |
NCT05863312 -
REtinal Detachment Outcomes Study
|
N/A | |
Recruiting |
NCT05561569 -
Air Versus Gas Tamponade in Primary Retinal Detachment
|
N/A | |
Not yet recruiting |
NCT05538156 -
Internal Limiting Membrane Peeling in Retinal Detachment Surgery
|
N/A | |
Completed |
NCT03046719 -
Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal
|
N/A | |
Recruiting |
NCT01261533 -
Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment
|
Phase 1 | |
Terminated |
NCT02068625 -
Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
|
Phase 4 | |
Completed |
NCT00000140 -
The Silicone Study
|
Phase 3 | |
Recruiting |
NCT05543018 -
Effect of Intraocular Tamponade on Visual Perception
|
N/A | |
Not yet recruiting |
NCT04518696 -
Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment
|
N/A | |
Completed |
NCT03321253 -
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
|
N/A | |
Completed |
NCT06166914 -
Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
|
N/A | |
Enrolling by invitation |
NCT05566626 -
Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera
|
N/A | |
Not yet recruiting |
NCT03631108 -
Feasibility Study and Preliminary Application Study on Iris OCTA
|
||
Recruiting |
NCT02201706 -
Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye
|
N/A | |
Completed |
NCT03218371 -
Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.
|
N/A | |
Completed |
NCT00000154 -
Diabetic Retinopathy Vitrectomy Study (DRVS)
|
Phase 3 |